Burberry Group PLC (LSE:BRBY) sunk 5.6% to 1557p as it reported a 35% drop in sales to mainland China in the 13 weeks to 2 July due to restrictions and store closures designed to control Covid-19 outbreaks.
Although the British luxury fashion house grew its global turnover by 5% in the first quarter despite “significant disruption from lockdowns in mainland China.”
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) said it expects net profits for the year just ended to meet forecasts even on reduced revenues.
The hay fever and vaccine specialist said revenues for the year to June 2022 will be £72.8mln or 14% below last year’s £84.3mln, due largely to a slimming down of the product portfolio with the removal of older products.
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has raised £20mln through a placing and retail offer via PrimaryBid, with the med-tech firm’s directors chipping in £130,000 through a management subscription.
The price of 80p was a 14.4% discount on the closing market price yesterday.
Roquefort Therapeutics PLC (LSE:ROQ) said trading in its shares has commenced on the OTCQB Venture Market in the US under the ticker ‘ROQAF’.
The biotech company, whose primary listing is on the main market of the London Stock Exchange, said cross trading on the OTCQB will give it access one of the world's largest investment markets to expand its reach into a broader pool of investors.
Scirocco Energy PLC (AIM:SCIR) has noted that Aminex does not intend to exercise its pre-emption rights over a 25% stake in the Ruvuma asset in Tanzania. Scirocco has agreed the sale of the stake to Wentworth Resources for US$16mln.
Mode Global Holdings PLC (LSE:MODE, OTCQB:MODGF) has detailed the director contribution of £65,000 to a £2mln convertible loan note issued announced on 13 July. Rita Liu, CEO, chipped in £20,000, with non-execs David Shrier and Michael Robertson subscribing £25,000 and £20,000 respectively.